NeoBiotechnologies antibody solutions for research

NeoBiotechnologies offers a comprehensive portfolio of highly validated antibodies designed to support reliable, reproducible results across cancer research, immunology, cell biology and translational science. Every antibody undergoes a rigorous development and validation process, including the use of HuProt™ Human Proteome Microarrays to assess specificity against more than 21,000 human proteins. From traditional monoclonal antibodies to recombinant and rabbit monoclonal formats, NeoBiotechnologies provides researchers with trusted tools for accurate target detection and biomarker analysis. 

This collection brings together NeoBiotechnologies' core antibody technologies, helping researchers select the most appropriate format for their application while benefiting from the company's commitment to quality, specificity and scientific rigour.

Monoclonal antibodies

NeoBiotechnologies develops highly validated monoclonal antibodies for cancer and biomedical research. Manufactured and validated in-house, these antibodies are designed to deliver the specificity, consistency and reproducibility researchers require for reliable results.

Key features

• Bind to a single, defined target epitope for highly specific protein detection.
• Developed and validated by NeoBiotechnologies' team of antibody specialists.
• Subjected to rigorous validation procedures to support reproducible performance.
• Available for a broad range of oncology, immunology and cell biology targets.

Recombinant antibodies

NeoBiotechnologies' recombinant antibodies combine precise target recognition with the consistency of recombinant production. By using defined antibody sequences, recombinant formats help minimise batch-to-batch variation and support long-term experimental reproducibility.

Key features

• Engineered using defined antibody sequences for greater consistency.
• Deliver reliable lot-to-lot performance across research workflows.
• Available in recombinant rabbit monoclonal formats for thousands of targets.
• Suitable for applications where reproducibility and long-term supply continuity are critical.

HuProt™ validated antibodies

NeoBiotechnologies uses HuProt™ Human Proteome Microarrays as part of its comprehensive antibody validation strategy. By screening antibodies against more than 21,000 full-length human proteins, this approach helps verify specificity and identify potential off-target interactions.

Key features

• Screened against over 21,000 full-length human proteins.
• Helps identify potential off-target binding and cross-reactivity.
• Provides added confidence in antibody specificity and reproducibility.
• Utilises one of the most comprehensive human protein collections available.

Rabbit monoclonal antibodies

NeoBiotechnologies offers an extensive portfolio of rabbit monoclonal antibodies, including recombinant rabbit monoclonal formats. These antibodies are particularly well suited to demanding applications such as immunohistochemistry, where sensitivity and specificity are essential.

Key features

• Extensive catalogue covering a wide range of research targets.
• Widely used for immunohistochemistry and tissue-based studies.
• Available in both traditional and recombinant monoclonal formats.
• Supported by NeoBiotechnologies' rigorous validation workflow.